Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Capital Employed: 2017-2024

Historic Return on Capital Employed for Akebia Therapeutics (AKBA) over the last 8 years, with Dec 2024 value amounting to -0.34%.

  • Akebia Therapeutics' Return on Capital Employed rose 32.00% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.34% for FY2024, which is 10.00% down from last year.
  • Akebia Therapeutics' Return on Capital Employed amounted to -0.34% in FY2024, which was down 44.50% from -0.23% recorded in FY2023.
  • Akebia Therapeutics' Return on Capital Employed's 5-year high stood at -0.23% during FY2023, with a 5-year trough of -0.81% in FY2021.
  • Its 3-year average for Return on Capital Employed is -0.28%, with a median of -0.26% in 2022.
  • In the last 5 years, Akebia Therapeutics' Return on Capital Employed dropped by 30bps in 2020 and then surged by 55bps in 2022.
  • Yearly analysis of 5 years shows Akebia Therapeutics' Return on Capital Employed stood at -0.73% in 2020, then declined by 9bps to -0.81% in 2021, then spiked by 55bps to -0.26% in 2022, then rose by 3bps to -0.23% in 2023, then dropped by 10bps to -0.34% in 2024.